Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-27

FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for esomeprazole strontium from R2 Pharma, LLC. This action authorizes the salt form of esomeprazole under its NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole strontium (Esomeprazole strontium)

Snippet

SUPPL AP for ESOMEPRAZOLE STRONTIUM (ESOMEPRAZOLE STRONTIUM)